Authors:
Jonsson, B
Buxton, M
Hertzman, P
Kahan, T
Poulter, N
Citation: B. Jonsson et al., Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT), J HUM HYPER, 15, 2001, pp. S53-S56
Citation: N. Poulter et B. Williams, Doxazosin for the management of hypertension: Implications of the findingsof the ALLHAT Trial, AM J HYPERT, 14(11), 2001, pp. 1170-1171
Authors:
Chalmers, J
Cooper, M
Ferrannini, E
Glasziou, P
Grobbee, D
Hamet, P
Harrap, S
Liu, L
MacMahon, S
Mancia, G
Marre, M
Matthews, D
Mogensen, C
Neal, B
Pan, CY
Poulter, N
Rodgers, A
Williams, B
Woodward, M
Citation: J. Chalmers et al., Study Rationale and Design of ADVANCE: Action in and vascular disease - preterax and diamicron MR evaluation, DIABETOLOG, 44(9), 2001, pp. 1118-1120
Authors:
Chapman, N
Mayet, J
Ozkor, M
Foale, R
Thom, S
Poulter, N
Citation: N. Chapman et al., Ethnic and gender differences in electrocardiographic QT length and QT dispersion in hypertensive subjects, J HUM HYPER, 14(6), 2000, pp. 403-405